• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自由基和局部青光眼药物的 pH 值:一生的眼部化学损伤?

Free radicals and the pH of topical glaucoma medications: a lifetime of ocular chemical injury?

机构信息

Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, UK.

出版信息

Eye (Lond). 2012 May;26(5):734-41. doi: 10.1038/eye.2012.25. Epub 2012 Mar 2.

DOI:10.1038/eye.2012.25
PMID:22388593
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3351058/
Abstract

INTRODUCTION

Preservatives in ophthalmic preparations are known to cause ocular surface damage. Excipients can also contribute to oxidative stress in the compromised ocular surface. We evaluated commonly used topical glaucoma medications to ascertain pH levels and the intrinsic presence of free radicals.

METHODS

Samples of 27 topical glaucoma preparations were analysed for total free radical presence using a Randox Kit for total antioxidant status. Analytical grade indicator paper was used to ascertain pH levels.

RESULTS

Free radical concentrations for these 27 glaucoma preparations ranged from 0 to 4.54 mmol/l, with a median value of 0.66 mmol/l (mean value of 0.662 mmol/l, SD 0.839). Levels of pH ranged from 4.0 to 7.4, with a median value of 6.5 (mean 6.252, SD 0.826). There was no evidence of a direct correlation between these two variables (r=0.232, P=0.275).

CONCLUSION

This study is the first to document the range of pH and concentrations of free radicals intrinsically present in commonly used glaucoma medications. Long-term exposure to preservatives, free radicals, and pH levels could all contribute to ocular surface damage. The effect of excipients could be responsible for patient intolerance when changing products in the compromised ocular surface.

摘要

简介

眼用制剂中的防腐剂已知会引起眼表损伤。赋形剂也会导致受损眼表的氧化应激。我们评估了常用的局部青光眼药物,以确定 pH 值和自由基的固有存在。

方法

使用 Randox 试剂盒评估 27 种局部青光眼制剂中总自由基的存在,以评估总抗氧化状态。使用分析级指示剂试纸确定 pH 值。

结果

这 27 种青光眼制剂中的自由基浓度范围为 0 至 4.54mmol/L,中位数为 0.66mmol/L(平均值为 0.662mmol/L,标准差为 0.839)。pH 值范围为 4.0 至 7.4,中位数为 6.5(平均值为 6.252,标准差为 0.826)。这两个变量之间没有直接的相关性(r=0.232,P=0.275)。

结论

这项研究首次记录了常用青光眼药物中固有存在的 pH 值和自由基浓度范围。长期接触防腐剂、自由基和 pH 值都可能导致眼表损伤。在受损眼表更换产品时,赋形剂的影响可能导致患者不耐受。

相似文献

1
Free radicals and the pH of topical glaucoma medications: a lifetime of ocular chemical injury?自由基和局部青光眼药物的 pH 值:一生的眼部化学损伤?
Eye (Lond). 2012 May;26(5):734-41. doi: 10.1038/eye.2012.25. Epub 2012 Mar 2.
2
Preservative-free treatment in glaucoma: who, when, and why.青光眼的无防腐剂治疗:对象、时机及原因
Eur J Ophthalmol. 2013 Jul-Aug;23(4):518-25. doi: 10.5301/ejo.5000270. Epub 2013 Mar 7.
3
[Preservatives in ophthalmology].[眼科中的防腐剂]
Ophthalmologe. 2012 Nov;109(11):1064-70. doi: 10.1007/s00347-012-2638-4.
4
Ocular surface changes in glaucoma patients related to topical medications.青光眼患者眼表变化与局部用药的关系。
Coll Antropol. 2015 Mar;39(1):47-9.
5
Topical glaucoma medications - Clinical implications for the ocular surface.局部用青光眼药物 - 对眼表面的临床影响。
Ocul Surf. 2022 Oct;26:19-49. doi: 10.1016/j.jtos.2022.07.007. Epub 2022 Jul 31.
6
Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives.青光眼患者的眼表疾病:联合用药及防腐剂的影响
Optom Vis Sci. 2015 Sep;92(9):e222-6. doi: 10.1097/OPX.0000000000000542.
7
[Advances in preservative-free glaucoma drops].[无防腐剂青光眼滴眼液的进展]
Oftalmologia. 2011;55(2):3-6.
8
Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.苯扎氯铵、聚季铵盐和 SofZia 保存的局部青光眼药物对人眼上皮细胞的影响。
Adv Ther. 2010 Nov;27(11):837-45. doi: 10.1007/s12325-010-0070-1. Epub 2010 Oct 7.
9
Commercially available ocular hypotensive products: preservative concentration, stability, storage, and in-life utilization.市售降眼压产品:防腐剂浓度、稳定性、储存及实际使用情况
J Glaucoma. 2001 Dec;10(6):483-6. doi: 10.1097/00061198-200112000-00008.
10
Presence of free radicals in intracameral agents commonly used during cataract surgery.眼内液中自由基的存在,这些自由基通常存在于白内障手术中所使用的眼内液中。
Br J Ophthalmol. 2010 Dec;94(12):1674-7. doi: 10.1136/bjo.2009.171009. Epub 2010 Jul 19.

引用本文的文献

1
Toxicity Evaluation of New Generic Latanost and Latacom as an Ophthalmic Formulation.新型通用型拉坦诺斯特和拉他康眼用制剂的毒性评估
J Curr Glaucoma Pract. 2021 Sep-Dec;15(3):139-143. doi: 10.5005/jp-journals-10078-1319.
2
Chemical Cross-Linking of Corneal Tissue to Reduce Progression of Loss of Sight in Patients With Keratoconus.化学交联角膜组织以减少圆锥角膜患者视力丧失的进展。
Transl Vis Sci Technol. 2021 Apr 29;10(5):6. doi: 10.1167/tvst.10.5.6.
3
Factors Predetermining Increased Aqueous Humour Flare in Long-Term Glaucoma Treatment.长期青光眼治疗中决定房水闪光增加的因素。
J Ophthalmol. 2020 Mar 23;2020:7345687. doi: 10.1155/2020/7345687. eCollection 2020.
4
Comparison of Two Combinations of Maximum Medical Therapy for Lowering Intraocular Pressure in Primary Open-angle Glaucoma.两种最大程度药物治疗组合降低原发性开角型青光眼眼压的比较
Korean J Ophthalmol. 2020 Feb;34(1):19-26. doi: 10.3341/kjo.2019.0094.
5
Preservatives in glaucoma medication.青光眼药物中的防腐剂。
Br J Ophthalmol. 2018 Nov;102(11):1497-1503. doi: 10.1136/bjophthalmol-2017-311544. Epub 2018 Jul 4.
6
EDTA chelation for symptomatic band keratopathy: results and recurrence.EDTA 螯合治疗症状性带状角膜病变:结果和复发。
Eye (Lond). 2018 Jan;32(1):26-31. doi: 10.1038/eye.2017.264. Epub 2017 Dec 1.
7
Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma.青光眼患者中与局部用药相关的眼表疾病的症状和体征。
Clin Ophthalmol. 2015 Apr 8;9:625-31. doi: 10.2147/OPTH.S81247. eCollection 2015.
8
Clinical outcomes of xeno-free expansion and transplantation of autologous ocular surface epithelial stem cells via contact lens delivery: a prospective case series.通过隐形眼镜递送进行无动物源自体眼表上皮干细胞的扩增和移植的临床结果:一项前瞻性病例系列研究
Stem Cell Res Ther. 2015 Mar 12;6(1):23. doi: 10.1186/s13287-015-0009-1.

本文引用的文献

1
Toxicological evaluation of preservative-containing and preservative-free topical prostaglandin analogues on a three-dimensional-reconstituted corneal epithelium system.含防腐剂和无防腐剂的局部前列腺素类似物在三维重建角膜上皮系统中的毒理学评价。
Br J Ophthalmol. 2011 Jun;95(6):869-75. doi: 10.1136/bjo.2010.189449. Epub 2011 Mar 22.
2
Long-term effect of BAK-free travoprost on ocular surface and intraocular pressure in glaucoma patients after transition from latanoprost.从拉坦前列素转换为无苯扎氯铵的曲伏前列素对青光眼患者眼表和眼压的长期影响。
J Glaucoma. 2012 Jan;21(1):60-4. doi: 10.1097/IJG.0b013e3181fc8129.
3
Preserved and unpreserved 12 anti-allergic ophthalmic solutions and ocular surface toxicity: in vitro assessment in four cultured corneal and conjunctival epithelial cell lines.保存和未保存的12种抗过敏眼科溶液与眼表毒性:在四种培养的角膜和结膜上皮细胞系中的体外评估
Biocontrol Sci. 2010 Dec;15(4):143-8. doi: 10.4265/bio.15.143.
4
Effects of timolol-related ophthalmic solutions on cultured human conjunctival cells.噻吗洛尔相关眼用制剂对培养的人结膜细胞的影响。
Jpn J Ophthalmol. 2010 Nov;54(6):615-21. doi: 10.1007/s10384-010-0881-2. Epub 2010 Dec 30.
5
Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost.使用含有苯扎氯铵(BAK)的拉坦前列素或不含BAK的曲伏前列素治疗的青光眼或高眼压症患者的眼表疾病
Clin Ophthalmol. 2010 Nov 3;4:1253-61. doi: 10.2147/OPTH.S14113.
6
Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.苯扎氯铵、聚季铵盐和 SofZia 保存的局部青光眼药物对人眼上皮细胞的影响。
Adv Ther. 2010 Nov;27(11):837-45. doi: 10.1007/s12325-010-0070-1. Epub 2010 Oct 7.
7
Presence of free radicals in intracameral agents commonly used during cataract surgery.眼内液中自由基的存在,这些自由基通常存在于白内障手术中所使用的眼内液中。
Br J Ophthalmol. 2010 Dec;94(12):1674-7. doi: 10.1136/bjo.2009.171009. Epub 2010 Jul 19.
8
Presence of free radicals in commonly used ophthalmic preparations.常用眼科制剂中自由基的存在情况。
Br J Ophthalmol. 2010 Apr;94(4):525-6. doi: 10.1136/bjo.2009.162495.
9
Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications.使用局部降眼压药物的青光眼患者的眼表不适患病率。
Cornea. 2010 Jun;29(6):618-21. doi: 10.1097/ICO.0b013e3181c325b2.
10
Preservatives in eyedrops: the good, the bad and the ugly.眼药水中的防腐剂:好的、坏的和丑的。
Prog Retin Eye Res. 2010 Jul;29(4):312-34. doi: 10.1016/j.preteyeres.2010.03.001. Epub 2010 Mar 17.